At 09:04 am, Nifty futures on the Singapore Exchange (SGX) were trading 14.15 points or 0.15 per cent higher at 9,167.50, indicating a flat start for the Indian market on Tuesday.
Here's a look at the top stocks that may remain in focus today
Pharma pack: After Jubilant Life Sciences and Cipla, media reports suggest a number of Indian companies such as Dr Reddy’s Laboratories, Natco Pharma, Strides Pharma Science and Zydus Cadila are in talks with the US-based Gilead Sciences for licensing Remdesivir, the experimental drug to treat Covid-19.
Aurobindo Pharma: Aurobindo Pharma, its promoter PV Ramprasad Reddy, his